+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Intravascular Temperature Management Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • July 2023
  • Region: Global
  • Expert Market Research
  • ID: 5855153
The global intravascular temperature management market attained a value of USD 304.7 million in 2022, driven by Increasing prevalence of critical conditions requiring therapeutic hypothermia and advancements in intravascular temperature management technology. The market is expected to grow at a CAGR of 3.1% during the forecast period of 2023-2031 to attain a value of USD 401.1 million by 2031.

Intravascular Temperature Management: Introduction

Intravascular temperature management refers to the medical technique of regulating the body's core temperature using specialized devices and methods applied within blood vessels. It involves the precise control of temperature using catheters or other devices inserted into blood vessels to either heat or cool the circulating blood. Intravascular temperature management has various uses and benefits in medical procedures and critical care settings.

The benefits of intravascular temperature management include:

  • Improved Patient Outcomes: Precise control of body temperature through intravascular temperature management techniques can help improve patient outcomes, especially in critical care settings. Therapeutic hypothermia has been shown to improve survival rates and neurological outcomes in cardiac arrest and other conditions
  • Neuroprotection: Therapeutic hypothermia induced through intravascular temperature management has neuroprotective effects, reducing the risk of brain damage and improving neurological recovery in certain conditions such as cardiac arrest and traumatic brain injury
  • Minimized Complications: Maintaining optimal body temperature during surgical procedures using intravascular temperature management devices helps reduce surgical site infections, postoperative complications, and patient discomfort
  • Enhanced Patient Comfort: Intravascular temperature management devices offer a non-invasive or minimally invasive approach to temperature regulation, improving patient comfort and reducing the need for external cooling or warming methods
  • Customizable and Precise Temperature Control: Intravascular temperature management allows precise temperature control, ensuring the desired therapeutic temperature is achieved and maintained accurately. The ability to customize temperature settings based on patient requirements and the specific condition being treated enhances the effectiveness of treatment
It is important to note that intravascular temperature management techniques should be performed by trained healthcare professionals, and patient monitoring is crucial to ensure safety and optimize treatment outcomes.

Intravascular Temperature Management Segmentations
The market can be categorised into type, medical condition, application, and region.

Market Breakup by Type

  • Intravascular Cooling
  • Intravascular Warming

Market Breakup by Medical Condition

  • Cardiac Arrest
  • Traumatic Brain Injury (TBI)
  • Stroke
  • Myocardial Infection
  • Others

Market Breakup by Application

  • Pre-Operative Care
  • Operative Care
  • Post-Operative Care
  • Perioperative Care
  • Acute/Critical Care

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Intravascular Temperature Management Overview
The intravascular temperature management market has experienced significant growth and is projected to continue expanding in the coming years. Several factors contribute to the positive market scenario.

One of the primary drivers of market growth is the increasing prevalence of cardiac arrests, traumatic brain injuries, and other critical conditions where therapeutic hypothermia is beneficial. Therapeutic hypothermia induced through intravascular temperature management has been shown to improve patient outcomes and reduce neurological damage in such situations. As awareness grows about the benefits of maintaining precise temperature control in critical care settings, the demand for intravascular temperature management devices is expected to rise.

Moreover, advancements in technology and the development of innovative intravascular temperature management devices have fuelled market growth. Manufacturers are introducing more advanced and user-friendly systems that offer precise temperature control, better patient monitoring capabilities, and improved safety features. These advancements enhance the effectiveness and ease of use of intravascular temperature management techniques, driving their adoption in hospitals and critical care settings.

Furthermore, the increasing focus on patient safety and the growing emphasis on evidence-based practices contribute to market expansion. Intravascular temperature management is becoming an integral part of standardized protocols in critical care, cardiac care, and neurocritical care. Healthcare providers are recognizing the benefits of maintaining optimal body temperature and are integrating intravascular temperature management techniques into their treatment strategies, leading to increased market demand.

Key players in the global intravascular temperature management market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the intravascular temperature management market are as follows:
  • Lonza Group
  • Bio-Rad Laboratories, Inc
  • Thermo Fisher Scientific
  • Qiagen NV
  • Promega Corporation
  • SignaGen Laboratories
  • Merck KGaA
  • Altogen Biosystems
  • Polyplus-transfection SA
  • Mirus Bio
*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Intravascular Temperature Management Market Overview
3.1 Global Intravascular Temperature Management Market Historical Value (2016-2022)
3.2 Global Intravascular Temperature Management Market Forecast Value (2023-2031)
4 Global Intravascular Temperature Management Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Intravascular Temperature Management Market Segmentation
5.1 Global Intravascular Temperature Management Market by Type
5.1.1 Market Overview
5.1.2 Intravascular Cooling
5.1.3 Intravascular Warming
5.2 Global Intravascular Temperature Management Market by Medical Condition
5.2.1 Market Overview
5.2.2 Cardiac Arrest
5.2.3 Traumatic Brain Injury (TBI)
5.2.4 Stroke
5.2.5 Myocardial Infection
5.2.6 Others
5.3 Global Intravascular Temperature Management Market by Application
5.3.1 Market Overview
5.3.2 Pre-Operative Care
5.3.3 Operative Care
5.3.4 Post-Operative Care
5.3.5 Perioperative Care
5.3.6 Acute/Critical Care
5.4 Global Intravascular Temperature Management Market by Region
5.4.1 Market Overview
5.4.2 North America
5.4.3 Europe
5.4.4 Asia Pacific
5.4.5 Latin America
5.4.6 Middle East and Africa
6 North America Intravascular Temperature Management Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Intravascular Temperature Management Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Intravascular Temperature Management Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.6 Australia
8.7 Others
9 Latin America Intravascular Temperature Management Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Intravascular Temperature Management Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Lonza Group
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Bio-Rad Laboratories, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Thermo Fisher Scientific
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Qiagen NV
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Promega Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 SignaGen Laboratories
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Merck KGaA
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Altogen Biosystems
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Polyplus-transfection SA
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Mirus Bio
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
  • *Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Lonza Group
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific
  • Qiagen NV
  • Promega Corporation
  • SignaGen Laboratories
  • Merck KGaA
  • Altogen Biosystems
  • Polyplus-transfection SA
  • Mirus Bio



Table Information